Sharing Trial Data

It is time that drug companies get with the program and accept that sharing of clinical trials data is a good thing, and should be more widely adopted, at the very least because it could engender more trust between pharmaceutical companies and patients, Nature writes in an editorial.

The comments were published on the heels of a new UK government report which said that drug makers have been routinely hiding clinical trial information from researchers and doctors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.